Chlorite-Detoxifying Microbial Communities in Chlorine Dioxide-Treated Cooling Systems: What Chlorite Dismutase Does and Does Not Mean
Chlorite dismutase removes the by-product, not the disinfectant. Why enrichment of chlorite-detoxifying bacteria in a chlorine dioxide-treated cooling circuit is not evidence of chlorine dioxide resistance, and what to check instead.
Some bacteria carry chlorite dismutase, an enzyme that converts chlorite, the main reduction product of chlorine dioxide, into chloride and oxygen. In a continuously dosed cooling circuit that trait can be selected for. It is easy to read that as 'resistance to chlorine dioxide'. It is not the same thing, and confusing the two leads to the wrong operational response. This PT11 guide separates chlorite detoxification from chlorine dioxide tolerance and explains what each means for data-centre and industrial cooling water.
Two different chemicals, two different microbial responses
Chlorine dioxide (ClO₂) is a radical oxidant. It kills by accepting an electron from cellular targets, notably thiol groups and other electron-rich sites in proteins, and in doing so it becomes chlorite (ClO₂⁻). Chlorite is a much weaker oxidant that persists in the water. In a chlorine dioxide-treated cooling circuit, therefore, the water carries two distinct chlorine species: the transient disinfectant and its accumulating, less reactive by-product. Bacteria can respond to each separately.
Tolerance of chlorine dioxide itself is a matter of surviving the oxidant: thicker matrix that consumes it before it reaches cells, reduced permeability, antioxidant systems, or simply living in the layer of a biofilm that the residual never reaches. That is the ordinary biofilm-tolerance story described elsewhere in this centre. Detoxification of chlorite is something else. A specific haem enzyme, chlorite dismutase (Cld), catalyses ClO₂⁻ → Cl⁻ + O₂. An organism that carries it can remove chlorite from its immediate surroundings. It gains nothing against chlorine dioxide by doing so, because chlorine dioxide has already acted by the time chlorite exists.
How widespread chlorite dismutase is
Chlorite dismutase was first characterised in bacteria that respire perchlorate and chlorate, where it disposes of the chlorite those pathways generate. It is now known to be far more widely distributed. A 2022 comparative-genomics analysis in The ISME Journal (Barnum and Coates, PMC9751292) found Cld genes in roughly five per cent of bacterial and archaeal genera, subject to extensive horizontal gene transfer, and often present in obligate aerobes that have no perchlorate-respiring machinery at all. The authors' interpretation is that chlorite, like hypochlorous acid, is encountered as an oxidative stress in ordinary habitats, and Cld is a defence against it. In their metagenome survey Cld was most enriched in oligotrophic rock, sediment and ice, followed by oxic wastewater and surface freshwater.
That distribution matters for cooling water because a recirculating tower is inoculated continuously by make-up water and by air. A Cld-carrying organism arriving in a circuit dosed with chlorine dioxide would experience a steady chlorite background and, if it can survive the chlorine dioxide itself, might gain a modest advantage. It is therefore plausible that continuous dosing enriches such organisms over time. That is a hypothesis, not an established finding: no study cited here has demonstrated it in a chlorine dioxide-treated cooling system, and a taxonomic survey alone cannot show that the enriched organisms carry or express Cld, or that chlorite was the selective pressure rather than temperature, nutrients or the oxidant itself. Confirming it would need gene- or function-level evidence (Cld detection or measured chlorite removal) alongside the water chemistry.
What the cooling-water and chlorine dioxide community studies actually show
Direct field evidence on chlorine dioxide-treated cooling systems is thin, and this guide does not cite a study that it could not verify. What the peer-reviewed literature does establish is the general pattern. A 2020 Water Research study of an industrial cooling tower (Pinel et al.) that combined flow cytometry, ATP and 16S rRNA sequencing over five months under continuous chlorination at about 0.35 to 0.41 mg Cl₂/L found that the tower community was seeded by the feed water and then shaped by differential decay: most members declined, but the order Obscuribacterales grew in the tower in the presence of the residual, with a recurrent net growth of about 260 per cent. A disinfectant residual, in other words, does not sterilise a tower; it filters the incoming community and lets the tolerant fraction expand.
For chlorine dioxide specifically, a 2024 study in the Journal of Hazardous Materials (Tang et al.; PubMed 39018597) characterised the 'disinfection-residual bacteria' that remain after chlorine dioxide treatment, reporting a shifted community structure, measurable regrowth potential and altered secretion characteristics compared with the untreated community. The organisms that remain after chlorine dioxide are not a random subset; they are the tolerant subset, and they can regrow when the residual lapses. Neither study identified chlorite dismutase as the mechanism, and neither concerned data-centre cooling in particular. They are cited here for the pattern, not for a mechanism they did not test.
Why the distinction changes the operational response
If a sequencing survey of a chlorine dioxide-treated circuit reports enrichment of taxa known to carry Cld, the tempting conclusion is that the biocide has stopped working and the dose should rise. That does not follow. Even if chlorite detoxification is confirmed, it means the by-product is being removed biologically, which, if anything, lowers measured chlorite in the bulk water. It says nothing about whether chlorine dioxide is reaching the biofilm at an effective concentration. The questions to ask are the ordinary ones: what is the chlorine dioxide residual at the far points of the circuit under load, is the make-up demand consuming it before it reaches the fill and heat exchangers, are deposits and scale shielding attached growth, and what do sessile counts or coupon inspections show?
Conversely, a genuine loss of control, rising planktonic counts and dipslide or coupon biofilm despite a maintained residual, is a chlorine dioxide-tolerance question, not a chlorite question. The response is to check contact, penetration and deposit control, review residual placement and monitoring points, and consider mechanical cleaning or a shock treatment within the product's label and applicable authorisation conditions or transitional evidence, and the site's written scheme. HSE's HSG274 Part 1 framework already provides the structure for that review.
Data-centre cooling specifics
Data-centre cooling towers and adiabatic systems run at high duty and often with high cycles of concentration to save water, so the make-up water's mineral and organic load is concentrated in the circuit. That raises chlorine dioxide demand and can raise chlorite accumulation, because more of the dose is consumed by non-microbial demand. It also means that blowdown, not biology, is the main route by which chlorite leaves the system. Operators reading a low chlorite result should establish whether it reflects low dosing, high blowdown, downstream reaction with iron or other reductants, or biological detoxification before drawing conclusions, and should not treat any of those as a proxy for microbial control.
Where a site uses a PT11 chlorine dioxide product that is authorised or supported by applicable transitional evidence for the intended use, its dosing, residual targets and monitoring belong to the product label and the site's written scheme. Nothing in the community studies discussed here sets a dose or a residual for any product, and no ChloroKlean product was tested in them.
Evidence and uncertainty
Published biofilm studies are valuable for understanding mechanisms, but their conditions may not match a particular installation. Species, surfaces, deposits and operating conditions should be recorded when interpreting evidence.
For safety-critical systems, decisions should be documented through the relevant risk assessment and management plan.
Choosing the next question
A useful next step is to identify what is known, what is inferred and what needs verification. This avoids treating a general reference as a site diagnosis.
Where a product is considered, confirm the intended use, lawful GB BPR route and label directions independently of this educational guide.
A proportionate biofilm-management approach
Use this sequence to frame investigation and control; it is not a dosing protocol.
Define the system and risk
Map wetted surfaces, operating conditions, users and relevant legal or sector guidance.
Gather evidence
Review inspection, operational, residual and microbiological records rather than relying on one indicator.
Address contributing conditions
Consider cleaning, hydraulics, nutrients, stagnation and equipment condition alongside any lawfully supplied biocide programme.
Verify and review
Document the intervention and review results through the site’s written scheme or hygiene plan.
Expert Insights
"Biofilm control is a system-management question: chemistry, surfaces, flow, cleaning and verification all matter."
ChloroKlean Technical Team
Technical review team
About the Reviewer
Gavin Owen
Managing Director, ChloroKlean
Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.
Frequently Asked Questions
Common questions about this topic, answered by our technical team.
Scope and safe-use note
- This is general educational information, not a dosing instruction or a product label.
- Use only a biocidal product that is authorised for its intended use or lawfully supplied under applicable GB BPR transitional arrangements, and follow its label, Safety Data Sheet and site risk assessment.
- Investigate system design, cleaning, monitoring and microbiological findings with a competent person where there is a health risk.
Published evidence about a disinfectant or another product does not establish efficacy, authorisation or an appropriate use pattern for any ChloroKlean product.
Related Resources
Continue exploring our knowledge base and product information.
Biofilm learning hub
Browse the connected biofilm guides.
Cooling-water biofilm and Legionella risk
Why attached growth in towers matters for Legionella management.
How chlorine dioxide damages bacterial cells
The thiol-oxidation mechanism that produces chlorite.
Mixed-species biofilms and disinfectant tolerance
How residuals reshape rather than remove communities.
UK limits for chlorine dioxide, chlorite and chlorate
Why chlorite must be measured, not calculated.
Biofilm monitoring and verification
What DNA-based surveys can and cannot show.
PT11 cooling water
Cooling-system product-type information.
Sources & References
This article references guidance from the following authoritative sources:
- Biofilms: survival mechanisms of clinically relevant microorganisms
Industry Standard - Frontiers in Microbiology (PMC)
- Legionella and the prevention of legionellosis
WHO - World Health Organization
- ACOP L8: Legionnaires' disease
HSE - Health and Safety Executive
- Biocidal Products Regulation
ECHA - European Chemicals Agency
- Chlorine redox chemistry is widespread in microbiology (2022)
Industry Standard - The ISME Journal (PMC9751292)
- Bacterial community dynamics and disinfection impact in cooling water systems (2020)
Industry Standard - Water Research
- Disinfection-residual bacteria (DRB) after chlorine dioxide treatment: microbial community structure, regrowth potential, and secretion characteristics (2024)
Industry Standard - Journal of Hazardous Materials (PubMed 39018597)
- HSG274 Part 2: The control of legionella in hot and cold water systems
HSE - Health and Safety Executive
External links open in a new window. ChloroKlean is not responsible for the content of external websites.